ALCAN-5 (Dapagliflozin) is a lower-dose prescription medication designed to manage type 2 diabetes. It is an SGLT2 inhibitor that helps lower blood sugar by increasing glucose excretion through urine. This medication is often prescribed for patients who require a milder dosage to achieve glycemic control while minimizing side effects. ALCAN-5 supports overall metabolic health and reduces the risk of diabetes-related complications.